290 related articles for article (PubMed ID: 30569219)
1. Perspectives of inclusion bodies for bio-based products: curse or blessing?
Slouka C; Kopp J; Spadiut O; Herwig C
Appl Microbiol Biotechnol; 2019 Feb; 103(3):1143-1153. PubMed ID: 30569219
[TBL] [Abstract][Full Text] [Related]
2. Custom made inclusion bodies: impact of classical process parameters and physiological parameters on inclusion body quality attributes.
Slouka C; Kopp J; Hutwimmer S; Strahammer M; Strohmer D; Eitenberger E; Schwaighofer A; Herwig C
Microb Cell Fact; 2018 Sep; 17(1):148. PubMed ID: 30236107
[TBL] [Abstract][Full Text] [Related]
3. Teaching an old pET new tricks: tuning of inclusion body formation and properties by a mixed feed system in E. coli.
Wurm DJ; Quehenberger J; Mildner J; Eggenreich B; Slouka C; Schwaighofer A; Wieland K; Lendl B; Rajamanickam V; Herwig C; Spadiut O
Appl Microbiol Biotechnol; 2018 Jan; 102(2):667-676. PubMed ID: 29159587
[TBL] [Abstract][Full Text] [Related]
4. IGF1 inclusion bodies: A QbD based process approach for efficient USP as well as early DSP unit operations.
Metzger KFJ; Padutsch W; Pekarsky A; Kopp J; Voloshin AM; Kühnel H; Maurer M
J Biotechnol; 2020 Mar; 312():23-34. PubMed ID: 32114153
[TBL] [Abstract][Full Text] [Related]
5. Inclusion Bodies: Status Quo and Perspectives.
Kopp J; Spadiut O
Methods Mol Biol; 2023; 2617():1-13. PubMed ID: 36656513
[TBL] [Abstract][Full Text] [Related]
6. Quality control of inclusion bodies in Escherichia coli.
Jürgen B; Breitenstein A; Urlacher V; Büttner K; Lin H; Hecker M; Schweder T; Neubauer P
Microb Cell Fact; 2010 May; 9():41. PubMed ID: 20509924
[TBL] [Abstract][Full Text] [Related]
7. Recombinant protein folding and misfolding in Escherichia coli.
Baneyx F; Mujacic M
Nat Biotechnol; 2004 Nov; 22(11):1399-408. PubMed ID: 15529165
[TBL] [Abstract][Full Text] [Related]
8. Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process.
Singh A; Upadhyay V; Upadhyay AK; Singh SM; Panda AK
Microb Cell Fact; 2015 Mar; 14():41. PubMed ID: 25889252
[TBL] [Abstract][Full Text] [Related]
9. Wanted: more monitoring and control during inclusion body processing.
Humer D; Spadiut O
World J Microbiol Biotechnol; 2018 Oct; 34(11):158. PubMed ID: 30341583
[TBL] [Abstract][Full Text] [Related]
10. Production of Active Recombinant Hyaluronidase Inclusion Bodies from
Schwaighofer A; Ablasser S; Lux L; Kopp J; Herwig C; Spadiut O; Lendl B; Slouka C
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485932
[TBL] [Abstract][Full Text] [Related]
11. Monitoring and control strategies for inclusion body production in E. coli based on glycerol consumption.
Slouka C; Kopp J; Strohmer D; Kager J; Spadiut O; Herwig C
J Biotechnol; 2019 Apr; 296():75-82. PubMed ID: 30904592
[TBL] [Abstract][Full Text] [Related]
12. A novel method to recover inclusion body protein from recombinant E. coli fed-batch processes based on phage ΦX174-derived lysis protein E.
Ehgartner D; Sagmeister P; Langemann T; Meitz A; Lubitz W; Herwig C
Appl Microbiol Biotechnol; 2017 Jul; 101(14):5603-5614. PubMed ID: 28429059
[TBL] [Abstract][Full Text] [Related]
13. Reassessment of inclusion body-based production as a versatile opportunity for difficult-to-express recombinant proteins.
Hoffmann D; Ebrahimi M; Gerlach D; Salzig D; Czermak P
Crit Rev Biotechnol; 2018 Aug; 38(5):729-744. PubMed ID: 29124949
[TBL] [Abstract][Full Text] [Related]
14. A simplified bioprocess for human alpha-fetoprotein production from inclusion bodies.
Leong SS; Middelberg AP
Biotechnol Bioeng; 2007 May; 97(1):99-117. PubMed ID: 17115449
[TBL] [Abstract][Full Text] [Related]
15. Role of the disaggregase ClpB in processing of proteins aggregated as inclusion bodies.
Zblewska K; Krajewska J; Zolkiewski M; Kędzierska-Mieszkowska S
Arch Biochem Biophys; 2014 Aug; 555-556():23-7. PubMed ID: 24943258
[TBL] [Abstract][Full Text] [Related]
16. Dynamic transcriptional response of Escherichia coli to inclusion body formation.
Baig F; Fernando LP; Salazar MA; Powell RR; Bruce TF; Harcum SW
Biotechnol Bioeng; 2014 May; 111(5):980-99. PubMed ID: 24338599
[TBL] [Abstract][Full Text] [Related]
17. Nucleic acids in inclusion bodies obtained from E. coli cells expressing human interferon-gamma.
Krachmarova E; Ivanov I; Nacheva G
Microb Cell Fact; 2020 Jul; 19(1):139. PubMed ID: 32652996
[TBL] [Abstract][Full Text] [Related]
18. Protein expression and refolding--a practical guide to getting the most out of inclusion bodies.
Cabrita LD; Bottomley SP
Biotechnol Annu Rev; 2004; 10():31-50. PubMed ID: 15504702
[TBL] [Abstract][Full Text] [Related]
19. The economics of inclusion body processing.
Lee GH; Cooney D; Middelberg AP; Choe WS
Bioprocess Biosyst Eng; 2006 Jul; 29(2):73-90. PubMed ID: 16718467
[TBL] [Abstract][Full Text] [Related]
20. Detailed small-scale characterization and scale-up of active YFP inclusion body production with Escherichia coli induced by a tetrameric coiled coil domain.
Lamm R; Jäger VD; Heyman B; Berg C; Cürten C; Krauss U; Jaeger KE; Büchs J
J Biosci Bioeng; 2020 Jun; 129(6):730-740. PubMed ID: 32143998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
